Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

Stock Information for Repare Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.